Replies to post #420082 on Anavex Life Sciences Corp (AVXL)

[abew4me]

One other point...

It is not uncommon for the market to give pharmaceutical companies a multiple of approximately 5x their gross revenue.

If Anavex treats just half the Rett population in the US, we would generate approx $4 Billion x 5x multiple = $20 Billion per year market cap.

Divide $20 Billion by 100 million shares and you get $200/share.

[tredenwater2]

Abew thank you for the Acadia info. I fjnd it absolutely disgusting to price our drug at $500,000 for something that may cost $1-$5 a day to produce. Even $10 a day or $100 a day x 365 days in a yr only equate to $3,650-$36,500 per year. Over 1,000 x the cost of production to make up for a decade of trials?

Sorry, not in my comprehension, I would make a bad CEO.

[jimmy_mcyoloswag]

"Although there is a publication reporting the efficacy of trofinetide in a Fragile X mouse model, there are currently no publications evaluating the efficacy of trofinetide in any animal model of Rett."

That's crazy.